Navigation Links
Sentillion Receives U.S. Patent for Administering Context Management Systems
Date:4/30/2008

Latest Patent Adds to Company's Extensive Patent Portfolio

ANDOVER, Mass., April 30 /PRNewswire/ -- Sentillion, the company that created healthcare single sign-on (SSO), announced that it has been issued a U.S. patent (6,993,556) for its technology upon which system administration tooling for the company's context management solution is based. Context management automatically synchronizes multiple applications in response to a single user gesture directed at any application using readily identifiable information such as a particular patient, encounter or observation. The patent covers core technology relating to setting up and maintaining context subject data definitions, intervening in context management operations, and providing security functions to protect sensitive context information against tampering by unauthorized users. Sentillion provides context management as part of its clinical workstation solution, Vergence. The invention covered by the patent makes it practical for healthcare organizations to deploy and maintain their Vergence system.

Using the patented technology, Sentillion's customers have been able to configure their Vergence systems to perform extremely sophisticated context management capabilities. For example, at one healthcare organization, using Vergence, if a physician reviews a patient's record in the hospital's primary clinical information system and then needs to evaluate images from the patient's chest CT, the simple click of an icon to open the PACS application presents the exact image desired. If the patient had multiple studies, then each selection made in the clinical information system results in the PACS application automatically displaying the associated image. Without Vergence, the physician might have to search through several screens, enter a patient's name or medical record number, or scroll through multiple studies searching for the desired result.

"For over a decade, Sentillion has been a thought leader in the healthcare industry and created the concept of context management which is now deployed at over 560 healthcare institutions worldwide. In addition to our newly patented administration tooling, Sentillion's innovative Bridge technology makes it possible to non-invasively context-enable any application whether it be Web, Windows or legacy-based. Using Sentillion's tools, healthcare organizations can deploy practical context management solutions that enable all types of caregivers to take full advantage of the many clinical applications that are available to them," said David Fusari, vice president and CTO, Sentillion.

Sentillion's identity and access management solutions are the most widely deployed in healthcare and are used daily by more than 350,000 caregivers in 560 unique hospitals across North America and the United Kingdom, including Eisenhower Medical Center, Great Ormond Street Hospital, Sisters of Mercy Health System, Sharp HealthCare and Texas Children's Hospital. Sentillion's patent portfolio also includes patents issued in the U.S. and in the E.U.

About Sentillion, Inc.

Since 1998, Sentillion has been revolutionizing healthcare IT with award winning, industry recognized identity and access management technology. Sentillion has successfully combined patented technology with a deep understanding of the healthcare industry to deliver the most comprehensive set of solutions for single sign-on, user provisioning, clinical workstations and virtualized remote access. Recently recognized as the number one single sign-on (SSO) vendor in the KLAS Top 20: 2007 Year-End Report, Sentillion is the only identity and access management company whose solutions are used daily by over 350,000 caregivers in leading healthcare organizations across North America and Europe. Sentillion is a privately held company headquartered in Andover, Mass. For more information, visit Sentillion at http://www.sentillion.com.

Contact:

Jennifer Haas

Sentillion

(978) 689-9095 x262

jennifer.haas@sentillion.com


'/>"/>
SOURCE Sentillion
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
2. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
3. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
4. Sentillion Launches Channel Partner Program for Healthcare-Specific Identity & Access Management Solutions
5. Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses
6. iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion
7. Sentillion Ranked #1 Vendor in KLAS Single Sign-On & Context Management Report
8. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
9. DaVita Receives Civil Complaint
10. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased to announce ... a longtime supporter of the event. , "We are pleased that KLS Martin is ... Havlik, 2017 ACPA President. "KLS Martin has a long track record of support of ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, ... symposium on “Doping in Sport: How the Culture Might Change,” in ... LLP. The symposium will be held at Pepperdine University in Malibu, California. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Healthcare ... for those in the fight against cancer, has produced a seminal study that ... HRA will release top-line findings in a webinar, Defining Compassionate Care Through the ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)... Feb. 23, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... innovative proprietary products for the urology market, will release ... ended December 31, 2016 before the market open on ... will host a conference call and webcast to discuss ... 9, 2017 at 11:00 a.m. Eastern Time (10:00 a.m. ...
Breaking Medicine Technology: